Form D · Other Health Care
GenomOncology, LLC
Cleveland, OH · CIK 0001549491
Offering snapshot reported Apr 29, 2020 · SEC filing
- Reported sold
- $3.2M Offering amount: $4.2M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 15, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 29, 2020 | Initial | $3,200,000 | No comparison | 10 | SEC filing |
| Nov 22, 2019 | Initial | $1,385,506 | No comparison | 13 | SEC filing |
| May 9, 2012 | Initial | $1,250,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-365946
Convertible Promissory Note and underlying preferred shares or units
Source: Form D, filed Apr 29, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Manuel J. Glynias | Director, Executive |
| Brian Laden | Director |
| Len Pagon | Director |
| Jonathan Seaton | Director |
| Jeff Smith | Executive |
| Brad Wertz | Director, Executive |
| Lee Zapis | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1138 West 9 Th Street Suite 400
Cleveland, OH, 44113
Cleveland, OH, 44113